Call FREE from a Landline or Mobile on 0800 634 75 75

Tumour Worry Linked To Breast Cancer Drug

breast-cancer-drugA scare has broken out over the breast cancer drug tamoxifen, with women being advised that the drug may, in certain circumstances, be responsible for an increased risk of secondary tumours. Medical charities have moved to play down the concerns but, according to the guardian website, US research has indicated that those using tamoxifen for a period of five years were more vulnerable to developing more aggressive tumours, as opposed to those which require oestrogen, which tamoxifen targets.

Tamoxifen works by impeding oestrogen production in women and is most commonly used by breast cancer patients following surgery to stop tumours returning. However, the indication is that the drug may quadruple the chance of a non-hormone sensitive tumour occurring instead. The findings have been recorded in the journal Cancer Research but scientists have been quick to point out the benefits of the drug. Dr Sarah Cant acknowledges that “Women with breast cancer should be aware of the risks of taking any course of treatment” but states that, “anyone who is concerned should not stop their medication and should speak to their doctor.”

The use of drugs such as tamoxifen is regulated by The Medicines and Healthcare products Regulatory Agency, a government agency. They ensure that medicines and medical devices are acceptably safe for use but acknowledge that no product is risk free. There are pros and cons with every treatment and it is a fine line to tread. If a medicine was allowed on to the market with inadequate testing then there would be strong claims to be made that the producers of the product and also the regulators might be found to have been negligent and those who suffered might be able to make a medical negligence claim for compensation.

Request A Call Back

Your Details
Accident Details
Select Your Call Back Time
NHS Email Leak
Search Our Blog
Free Instant Valuation
As Seen on TV
Latest Blog Posts

Bigen Hair Dye removed from shelves over fears it can harm unborn babies and women's fertility

Bigen Hair Dye removed from shelves over fears it can harm unborn babies and women's fertility

The EU's Rapid Alert System (Rapex) has issued a European-wide alert concerning Bigen Hair Dye products that have been found to contain a toxin that can damage unborn babies and harm ...

Published on the 10/02/2016


My GP wont refer me - help!

My GP wont refer me - help!

A failure to be referred for treatment or more investigation is one of the common types of medical negligence claims we help people with here at The Injury Law...

Published on the 15/01/2016


Several commuters injured in Reading Railway Station escalator accident

Several commuters injured in Reading Railway Station escalator accident

According to news reports, more than 40 people have been injured at Reading Railway Station at around 7:30am at platform 14 during the busy commuting hours on Wednesday 6th January 2016. ...

Published on the 15/01/2016


Clinical negligence: A failure to refer

Clinical negligence: A failure to refer

One of the most common types of medical negligence compensation claims that we help victims for, involve a failure by the NHS ...

Published on the 21/12/2015


Can a UK lawyer fight your accident abroad claim?

Can a UK lawyer fight your accident abroad claim?

The short answer is: yes! It does however depend on a number of factors like where the accident happened; how it was caused; and perhaps most importantly, how your trip abroad was arranged. The ...

Published on the 21/12/2015


55 Patients suffered horrific side effects of 'unnecessary' chemotherapy and kept in the dark for six years

55 Patients suffered horrific side effects of 'unnecessary' chemotherapy and kept in the dark for six years

News reports have emerged about allegations against two doctors practising under the Royal Wolverhampton NHS Trust who allegedly administered extra strong doses of chemotherapy to patients who apparen...

Published on the 20/10/2015


Coloplast A/S - temporary suspension of CE certification for Testicular implants and inflatable vaginal stents

Coloplast A/S - temporary suspension of CE certification for Testicular implants and inflatable vaginal stents

Our Medical and Product Lawyers have a lot of experience in fighting for the rights of those affected by medical device recalls and claims. We have acted for a large number of victims of the PIP breas...

Published on the 20/10/2015


Public Liability - a quick guide!

Public Liability - a quick guide!

It is clear that any person who occupies a property owes a duty of care for the safety of any person who legally uses the premises. In places such as shops, restaurants, high street service branches, ...

Published on the 06/10/2015


Manual handling at work - a quick guide!

Manual handling at work - a quick guide!

If you have found yourself having to manoeuvre objects at work, and as a result you injure yourself, we may be able to claim compensation on your behalf. As it stands, the law is clear that your em...

Published on the 06/10/2015


The Provision and Use of Equipment at Work - Quick Help Guide

The Provision and Use of Equipment at Work - Quick Help Guide

Over the years at The Injury Lawyers, our specialist team have been dedicated to securing maximum compensation for employees injured through the use of equipment at work. Any employee who is involv...

Published on the 06/10/2015


Categories
Archives